Edition:
United States

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

2.39USD
16 Feb 2018
Change (% chg)

$0.04 (+1.70%)
Prev Close
$2.35
Open
$2.36
Day's High
$2.45
Day's Low
$2.22
Volume
620,907
Avg. Vol
414,654
52-wk High
$4.09
52-wk Low
$1.59

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 34.52 34.43
P/E High - Last 5 Yrs. -- 41.29 46.75
P/E Low - Last 5 Yrs. -- 21.02 24.14
Beta 0.28 0.79 0.81
Price to Sales (TTM) 187.56 7.44 8.57
Price to Book (MRQ) -- 14.31 5.14
Price to Tangible Book (MRQ) -- 23.27 6.30
Price to Cash Flow (TTM) -- 23.42 25.75
% Owned Institutions -- 4.45 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.95 1.52
Dividend Yield - 5 Year Avg -- 1.14 2.01
Dividend 5 Year Growth Rate -- 17.56 5.27
Payout Ratio(TTM) -- 28.88 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.35 14.32 9.45
Sales (TTM) vs TTM 1 Yr. Ago -42.76 10.96 7.30
Sales - 5 Yr. Growth Rate -5.00 8.95 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -54.02 74.94 20.15
EPS (TTM) vs TTM 1 Yr. Ago -28.03 -- --
EPS - 5 Yr. Growth Rate -- 19.71 11.48
Capital Spending - 5 Yr. Growth Rate 36.90 9.68 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.14 2.43 2.42
Current Ratio (MRQ) 0.22 3.20 3.38
LT Debt to Equity (MRQ) -- 28.30 11.85
Total Debt to Equity (MRQ) -- 32.31 15.12
Interest Coverage (TTM) -149.72 19.93 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 17.36 57.95 54.90
Gross Margin - 5 Yr. Avg. 50.95 57.58 52.64
EBITD Margin (TTM) -153.74 -- --
EBITD - 5 Yr. Avg -110.22 23.21 9.86
Operating Margin (TTM) -244.46 18.56 1.25
Operating Margin - 5 Yr. Avg. -131.86 15.93 5.07
Pre-Tax Margin (TTM) -244.96 18.25 2.12
Pre-Tax Margin - 5 Yr. Avg. -125.55 16.14 5.33
Net Profit Margin (TTM) -244.96 13.90 -1.38
Net Profit Margin - 5 Yr. Avg. -125.55 11.22 1.62
Effective Tax Rate (TTM) -- 22.14 22.03
Effective Tax Rate - 5 Yr. Avg. -- 29.18 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 50,211 29,190,370 819,569,446
Net Income/Employee (TTM) -122,994 3,676,582 95,804,981
Receivable Turnover (TTM) 10.46 4.83 5.40
Inventory Turnover (TTM) 3.58 3.02 3.48
Asset Turnover (TTM) 0.80 0.75 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -195.99 10.57 10.68
Return on Assets - 5 Yr. Avg. -60.29 8.94 12.00
Return on Investment (TTM) -- 14.12 13.54
Return on Investment - 5 Yr. Avg. -76.85 11.68 15.72
Return on Equity (TTM) -- 16.75 14.80
Return on Equity - 5 Yr. Avg. -79.39 14.09 16.91
  1 Year 3 Year 5 Year
Sales % -42.76 -18.76 -5.00
EPS (TTM) % -28.09 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Antares Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.